About Vesicor Therapeutics
Vesicor Therapeutics is a private company based in San Gabriel, California. It has reported $715,000 raised in two offerings on Form D since September 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 3, 2024 | May 14, 2025 | $515,000of $3.0M target | 12 | $42,917 | Equity, Options, Common Stock and Warrants to Purchase Common StockRule 506(b) | Form D ↗ |
| Sep 7, 2023 | Sep 14, 2023 | $200,000of $3.0M target | 2 | $100K | Equity, Options, Common Stock and Warrants to Purchase Common StockRule 506(b) | Form D ↗ |
| Total, two offerings | $715,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Vesicor Therapeutics's Form D filed May 14, 2025.
MB
Michael Bowen
Chief Financial Officer
WH
Warren Jr. Hosseinion
Executive officer
OL
Oded Levy
Director
LF
Luo Feng
Executive officer and director
WH
Warren Hosseinion
Director
Earlier filings also listed Warren Hosseinionn (director, last listed Sep 2023).